Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: A MER/LEO cohort analysis

Authors

Danny Luan, Weill Cornell Medical College
Tolulope Fatola, Weill Cornell Medical College
Ahmed Toure, Weill Cornell Medical College
Christopher R Flowers, University of Texas MD Anderson Cancer Center
Brian Link, University of Iowa
Jonathan W Friedberg, University of Rochester
Jonathon B Cohen, Emory University
Brad Kahl, Washington University School of Medicine in St. Louis
Izidore S Lossos, University of Miami
Loretta Nastoupil, University of Texas MD Anderson Cancer Center
Matthew J Maurer, Mayo Clinic
James R Cerhan, Mayo Clinic
Peter Martin, Weill Cornell Medical College

Journal

Blood Advances

Publication Date

8-9-2022

Volume

6

Issue

15

First Page

4413

Last Page

4423

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2022007687

Rights and Permissions

Luan D, Fatola T, Toure A, Flowers CR, Link B, Friedberg JW, Cohen JB, Kahl B, Lossos IS, Nastoupil L, Maurer MJ, Cerhan JR, Martin P. Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis. Blood Adv. 2022 Aug 9;6(15):4413-4423. doi: 10.1182/bloodadvances.2022007687 © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Luan, Danny; Fatola, Tolulope; Toure, Ahmed; Flowers, Christopher R; Link, Brian; Friedberg, Jonathan W; Cohen, Jonathon B; Kahl, Brad; Lossos, Izidore S; Nastoupil, Loretta; Maurer, Matthew J; Cerhan, James R; and Martin, Peter, "Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: A MER/LEO cohort analysis." Blood Advances. 6, 15. 4413 - 4423. (2022).
https://digitalcommons.wustl.edu/oa_4/332